Balance Sheet for Kiniksa Pharmaceuticals Ltd. (KNSA)

$ 22.46   0.47 (+2.14%) Volume: 150.45k 4:00 PM EDT Jul 15, 2020
After Hours:  $ 22.60   0.14 (+0.62%) Volume: 3.46k 7:57 PM EDT Jul 15, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016
Cash and Equivalents 46,928 71,976 45,555 55,970
Restrictable Cash - - 105 105
Marketable Securities 186,452 235,328 - -
Accounts Receivable - - - -
Loans Receivable - - - -
Other Receivables - - - -
Receivables - - - -
Inventories, Raw Materials - - - -
Inventories, Work in Progress - - - -
Inventories, Purchased Components - - - -
Inventories, Finished Goods - - - -
Inventories, Other - - - -
Inventories, Adjustments & Allowances - - - -
Inventories - - - -
Prepaid Expenses 8,247 6,446 1,444 259
Current Deferred Income Taxes - - - -
Other Current Assets - - - -
Total Current Assets 241,627 313,750 47,104 56,334
Land and Improvements - - - -
Buildings and Improvement 3,627 2,676 - -
Machinery, Furniture and Equipment 5,076 3,447 177 108
Construction in Progress 20 552 - -
Fixed Assets, Other 1,927 - - -
Fixed Assets, Total 10,650 6,675 177 108
Gross Fixed Assets 10,650 6,675 177 108
Accumulated Depreciation (2,325) (319) (52) (24)
Net Fixed Assets 8,325 6,356 125 84
Intangibles - - - -
Cost in Excess - - - -
Non-Current Deferred Income Taxes 4,372 1,216 238 41
Other Non-Current Assets 210 210 - -
Total Non-Current Assets 12,907 8,215 388 133
Total Assets 254,534 321,965 47,492 56,467
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016
Accounts Payable 5,693 10,918 1,218 212
Short Term Debt 1,697 - - -
Notes Payable - - - -
Accrued Expenses 13,326 25,740 14,642 1,104
Accrued Liabilities 13,326 25,740 14,642 1,104
Deferred Revenues - - - -
Current Deferred Income Taxes (3,156) (978) (197) (46)
Other Current Liabilities 7,114 5,896 1,570 986
Total Current Liabilities 27,830 42,554 17,430 2,302
Long Term Debt N/A N/A N/A -
Deferred Income Tax - 144 - -
Other Non-Current Liabilities 326 144 - -
Minority Interest - - - -
Capital Lease Obligations 955 - - -
Preferred Securities of Subsidiary Trust - - - -
Preferred Equity Outside Shareholders' Equity - - 119,770 79,897
Total Non-Current Liabilities 1,281 144 119,770 79,897
Total Liabilities 29,111 42,698 137,200 82,199
Preferred Shareholder's Equity - - - -
Common Shareholder's Equity 225,423 279,267 (89,708) (25,732)
Common Par 15 13 1 1
Additional Paid in Capital 581,467 473,483 1,289 392
Cumulative Translation Adjustments - - - -
Retained Earnings (356,092) (194,225) (90,998) (26,125)
Treasury Stock - - - -
Other Equity Adjustments 33 (4) - -
Total Capitalization 225,423 279,267 (89,708) (25,732)
Total Equity 225,423 279,267 (89,708) (25,732)
Total Liabilities & Shareholder's Equity 254,534 321,965 47,492 56,467
Cash Flow (160,434) (102,090) (64,874) (23,973)
Working Capital 213,797 271,196 29,674 54,032
Free Cash Flow (161,572) (86,302) (50,288) (21,870)
Invested Capital 225,423 279,267 (89,708) (25,732)
Shares Outstanding - Common Class Only 54,938 49,490 - -
Preferred Shares Outstanding - - - -
Total Ordinary Shares 54,938 49,490 46,963 46,963
Total Common Shares Outstanding 54,938 49,490 - -
Treasury Shares - - - -
Basic Weighted Shares Outstanding 54,049 29,547 32,467 32,467
Diluted Weighted Shares Outstanding 54,049 29,547 32,467 32,467